Drug Shortage Report for VISKEN
| Report ID | 122899 |
| Drug Identification Number | 00443174 |
| Brand name | VISKEN |
| Common or Proper name | pindolol |
| Company Name | XEDITON PHARMACEUTICALS INC |
| Market Status | MARKETED |
| Active Ingredient(s) | PINDOLOL |
| Strength(s) | 10MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 100 |
| ATC code | C07AA |
| ATC description | BETA BLOCKING AGENTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2020-08-21 |
| Estimated end date | |
| Actual end date | 2021-12-01 |
| Shortage status | Resolved |
| Updated date | 2021-12-15 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2020 WINSTON PARK DRIVE OAKVILLE, ONTARIO CANADA L6H 6X7 |
| Company contact information | george.gafrey@xediton.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2021-12-15 | French | Compare |
| v5 | 2021-12-15 | English | Compare |
| v4 | 2020-09-21 | French | Compare |
| v3 | 2020-09-21 | English | Compare |
| v2 | 2020-08-24 | French | Compare |
| v1 | 2020-08-24 | English | Compare |
Showing 1 to 6 of 6